Gene: [07q22/PLGAI1] plasminogen activator inhibitor, type I (endothelial); [PLANH1 PAI1 ]


GEN

The gene length is 12.3 kb. Exons: 9; introns: 8 (Strandberg-1988).

FUN

The product of gene PLGAI1 inhibits both types of plasminogen activators, thus participating in fibrinolysis, ovulation, cell migration etc."

MOP

The molecular product is a glycoprotein with MM 50 kD.

FAG

[1] The gene PLGAI1 is included in a group of functionally related genes. Their symbols are changed in the HUGEN Catalogue so that most of them begin with 'PLG'. These genes are: PLG - plasmin (an active product of plasminogen, GEM:06q2/PLG); PLI - plasmin inhibitor or antiplasmin (GEM:17p1/PLI); PLGL - plasminogen-like gene (GEM:02^/PLGL); PLGAT - tissue plasminogen activator (GEM:08p1/PLGAT); PLGAU - urokinase plasminogen activator (GEM:10q24/PLGAU); PLGAUR - receptor for urokinase plasminogen activator (GEM:19q132/PLGAUR); PLGAI1 - endothelial inhibitor of plasminogen activators (GEM:07q22/PLGAI1); PLGAI2 - placental inhibitor of plasminogen activators (GEM:18q221/PLGAI2); PLGAI2L1- PLGAI2-like 1 (GEM:00.0/PLGAI2L1); PLGAI2L2- PLGAI2-like 2 (GEM:00.0/PLGAI2L2); PLGAI3 - inhibitor of plasminogen activators, type III (GEM:14q321/PCI); at least two other types of inhibitors of activators have been typed by immunological methods;
[2] The product of PLGAI1 is also a component of the superfamily of serine protease inhibitors (serpins)."

REF

CLO,EXP,MEB "Alessi &: Eur J Biochem, 175, 531-540, 1988
CLO,SEQ,EXP "Ginsburg D &: J Clin Invest, 78, 1673-1680, 1986
LOC,LIN,MOL "Klinger KW &: PNAS, 84, N23, 8548-8552, 1987
SEQ,GEN,MOP,EAG "Strandberg L &: Eur J Biochem, 176, 609-616, 1988
CLO,SEQ,EXP "Van Zonneveld AJ &: PNAS, 85, N15, 5525-5529, 1988
REV,SEQ,FAG,FUN,MEB "Wun T-C: CRC Crit Rev Biotech, 8, N2, 131-148, 1988

SWI

SWISSPROT: P05121

KEY

hem, clot, pep

CLA

coding, basic

LOC

07 q22

MIM

MIM: 173360

SYN

PLANH1 PAI1

Смотрите также:

  • Трансген c-myc: связь с лимфомогенезом
  • Gene: [03^/PROS1] protein S, alpha (activated protein-C cofactor; vitamin K-dependent); thromboembolic disease, recurrent venous; [PROS ]
  • Ангиогенеза ингибиторы: Уменьшение при прогрессии опухоли
  • Тромбин: влияние на активность транскрипционных факторов